Browsing by Author "Jara, Lilian"

Now showing items 1-3 of 3

    • Diversity of clinical, radiographic and genealogical findings in 41 families with amelogenesis imperfecta 
      Adorno Farías, Daniela; Ortega Pinto, Ana; Gajardo, Paulina; Salazar, Ana; Morales Bozo, Irene; Werlinger, Fabiola; Rojas-Flores, Sandra; Molina Berríos, Alfredo Enrique; Echeverría-López, Sonia; Jara Sandoval, José; Jara, Lilian; Urzúa Orellana, Blanca (Bauru School of Dentistry, University of Sao Paulo, 2019)
      Amelogenesis imperfecta (AI) is a group of enamel development disorders that alter the structure and chemical composition of the tissue. There is great variability in the clinical presentation; according to Witkop, AI can ...
    • Immunotherapeutic potential of mollusk hemocyanins in combination with human vaccine adjuvants in murine ... 
      Román, Juan José Mora; Del Campo, Miguel; Villar, Javiera; Paolini, Francesca; Curzio, Gianfranca; Venuti, Aldo; Jara, Lilian; Ferreira, Jorge; Murgas, Paola; Lladser, Alvaro; Manubens, Augusto; Becker, María Inés (Hindawi Limited, 2019)
      Mollusk hemocyanins have been used for decades in immunological and clinical applications as natural, nontoxic, nonpathogenic, and nonspecific immunostimulants for the treatment of superficial bladder cancer, as ...
    • Polymorphisms in RAS/RAF/MEK/ERK pathway are associated with gastric cancer 
      González Hormazábal, Patricio; Musleh, Maher; Bustamante, Marco; Stambuk, Juan; Pisano, Raul; Valladares, Hector; Lanzarini, Enrique; Chiong, Hector; Rojas, Jorge; Suazo, Jose; Gonzalo Castro, V.; Jara, Lilian; Berger, Zoltan (MDPI AG, 2019)
      The RAS/RAF/MEK/ERK pathway regulates certain cellular functions, including cell proliferation, differentiation, survival, and apoptosis. Dysregulation of this pathway leads to the occurrence and progression of cancers ...